Integer Holdings Corporation

ITGR • Medical - Devices

$126.50

— 0.00 (0.00%)

ResultadosÚltimo reporte: 3 jul 2026

PERFIL EQUILIBRADONeutralConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Perfil mixto. La empresa no es necesariamente mala, pero la valoración, el crecimiento o el balance todavía no justifican una señal más fuerte.

Capitalización

$4.32B

Crecimiento

8.5%

Flujo de caja

5/5

Tendencia

Stable

Evidencia

Crecimiento positivo de ingresos · 9.5%Flujo de caja libre positivo · 3.03Flujo de caja libre consistente · 5/5Nivel de deuda manejable · 0.8Liquidez saludable · 3.32

Datos financieros hasta: 3 jul 2026, 12:00 a.m. UTCÚltima actualización de earnings: 3 jul 2026, 12:00 a.m. UTCÚltima actualización del perfil: 7 ago 2026, 2:01 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$126.50

Change0.00%

Shares Out34.15M

Market Cap$4.32B

Enterprise Value$5.54B

52W Range62.00 - 126.14

Beta0.64

P/E33.64

P/S2.35

P/B2.51

P/FCF32.89

EV/Sales3.01

Price$126.50

Change0.00%

Shares Out34.15M

Market Cap$4.32B

Enterprise Value$5.54B

52W Range62.00 - 126.14

Beta0.64

P/E33.64

P/S2.35

P/B2.51

P/FCF32.89

EV/Sales3.01

EV/EBITDA17.49

EV/FCF42.22

Earnings Yield2.97%

FCF Yield3.04%

Dividend Yield0.00%

Gross Margin23.06%

Oper. Margin11.33%

Profit Margin5.57%

Debt/Eq0.80

Current Ratio3.32

Quick Ratio2.23

Revenue 5Y8.52%

Target$118.25

Target Upside-6.52%

Target Median$121.00

Target Range104.00 - 127.00

Volume84.02K

Avg Volume717.31K

EPS Surprise-0.01

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

52/100

Fortaleza financiera

Deuda, caja, estabilidad

80/100

Potencial de crecimiento

Ingresos y expansión

60/100

Atractivo del precio

Barata o cara hoy

73/100

Por qué este puntaje▼

Crecimiento positivo de ingresos · 9.5%Flujo de caja libre positivo · 3.03Flujo de caja libre consistente · 5/5Nivel de deuda manejable · 0.8Liquidez saludable · 3.32

Analyst view

Analyst sentiment and price target

ITGR

Analyst sentiment

Based on 16 analyst votes · 2026-09-05

75/100

Bullish

Hold

Bearish

Precio objetivo

2026-08-07

Bajo

$101.00

Promedio

$114.80

Mediana

$115.00

Alto

$127.00

Resumen de la compañía

IPO: 9/29/2000

Industria: Medical - Devices

P/B i: 2.51

Deuda / Patrimonio i: 0.80

Margen operativo: 11.33%

Margen neto: 5.57%

ROE i: -

ROIC: -

Salud financiera

Puntaje16 / 20

Deuda / Patrimonio: 0.80

Ratio corriente: 3.32

Ratio rápido: 2.23

Estado: Strong

Transacciones internas

Actividad reciente de ejecutivos e insiders

Metcalf Milo Stephen II

Transacción: 07/06/2026

COMPRA

Cambio

+892

Precio

Not reported

Presentación

07/10/2026

Tipo

COMPRA

Metcalf Milo Stephen II

Transacción: 07/06/2026

OTRO

Cambio

Precio

Not reported

Presentación

07/10/2026

Tipo

OTRO

Thor Kirk K

Transacción: 06/30/2026

VENTA

Cambio

-6,120

Precio

Not reported

Presentación

07/01/2026

Tipo

VENTA

Insider	Tipo	Cambio	Precio	Transacción	Presentación
Metcalf Milo Stephen II	COMPRA	+892	Not reported	07/06/2026	07/10/2026
Metcalf Milo Stephen II	OTRO	0	Not reported	07/06/2026	07/10/2026
Thor Kirk K	VENTA	-6,120	Not reported	06/30/2026	07/01/2026
Thor Kirk K	VENTA	-2,409	$93.45	06/30/2026	07/01/2026
Harris John A	COMPRA	+1,096	Not reported	06/29/2026	07/01/2026
Spence Donald J	COMPRA	+2,623	Not reported	05/20/2026	05/22/2026
PASSERINI FILIPPO	COMPRA	+1,967	Not reported	05/20/2026	05/22/2026
Flanagan James Francis	COMPRA	+1,967	Not reported	05/20/2026	05/22/2026
Antrum Sheila	COMPRA	+1,967	Not reported	05/20/2026	05/22/2026
Capps Cheryl C	COMPRA	+1,967	Not reported	05/20/2026	05/22/2026
Jeffers Alvin Tyrone	COMPRA	+1,967	Not reported	05/20/2026	05/22/2026
Kapito Aaron	COMPRA	+1,967	Not reported	05/20/2026	05/22/2026
COYLE MICHAEL J	COMPRA	+1,967	Not reported	05/20/2026	05/22/2026
Hinrichs James F.	COMPRA	+1,967	Not reported	05/20/2026	05/22/2026
MAXWELL MARTIN C	COMPRA	+1,967	Not reported	05/20/2026	05/22/2026
Thomas Tommy P	COMPRA	+666	Not reported	05/18/2026	05/22/2026
Stephens Jim	VENTA	-1,472	Not reported	05/15/2026	05/19/2026
Stephens Jim	COMPRA	+491	Not reported	05/15/2026	05/19/2026
Smith Diron	VENTA	-2,063	Not reported	05/08/2026	05/12/2026
Smith Diron	VENTA	-503	$88.12	05/08/2026	05/12/2026

Sobre la compañía

Integer Holdings Corporation

Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.

Fuente - Link

Competidores

ADUS AORT CON HAE INSP LIVN PINC PRCT RXRX UFPT

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

How Could KKR's $5.7 Billion Buyout Reshape ITGR for Shareholders?

Integer's $5.7 billion KKR buyout offers shareholders $127 per share in cash, but closing still hinges on stockholder and regulatory approvals.

Zacks Investment Research

Integer Holdings Corporation Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights – ITGR

LOS ANGELES--(BUSINESS WIRE)---- $ITGR--Integer Holdings Corporation Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights – ITGR.

Business Wire

GMED or ITGR: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Integer (ITGR). But which of these two stocks is more attractive to value investors?

Zacks Investment Research

ITGR Investors Have Opportunity to Join Integer Holdings Corporation Fraud Investigation with SBS Law

Schall, Brown and Schwartz LLP (âSBSâ), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of inv

GuruFocus

ITGR Investors Have Opportunity to Join Integer Holdings Corporation Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)---- $ITGR--ITGR Investors Have Opportunity to Join Integer Holdings Corporation Fraud Investigation with SBS Law.

Business Wire

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-04-30	1.21	1.2	-0.01
2026-02-19	1.7	1.76	0.06
2025-10-23	1.68	1.79	0.11
2025-07-24	1.57	1.55	-0.02
2025-04-24	1.27	1.31	0.04
2025-02-20	1.46	1.43	-0.03
2024-10-24	1.36	1.43	0.07
2024-07-25	1.24	1.3	0.06
2024-04-25	1.12	1.14	0.02
2024-02-15	1.34	1.39	0.05
2023-10-26	1.05	1.27	0.22
2023-07-27	0.99	1.14	0.15